Logo

ABI and Invitrogen Join Forces on Labeling Reagents for Proteomics

Jun 06, 2005

NEW YORK, June 6 (GenomeWeb News) - Applied Biosystems and Invitrogen will co-market and re-sell their respective protein-labeling technologies for quantitative proteomics and biomarker studies, the companies said today.

 

Under the agreement, the companies will jointly sell ABI's iTRAQ and ICAT protein and peptide labeling reagents, and Invitrogen's new SILAC metabolomic labeling technology. ABI will also support Invitrogen's SILAC technology with software on its TOF/TOF mass spectrometers and plans to extend software support to other mass spec types.

 

In addition, the companies said they will co-develop and co-market protein sample preparation kits for mass spectrometry, as well as other reagents such as matrices, solubilizers, and calibrants.

 

Neither company disclosed financial terms of the agreement.

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.